Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.
WTHI News10

Union Health ER doctor urges residents to pay attention to emergency symptoms during dangerously cold weather conditions

As cold weather grips the Wabash Valley, residents are urged to be vigilant about the risks of frostbite and heart attacks.

Aspire Biopharma Holdings, Inc.: Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel to Address Gastric ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.Clopidogrel, currently sold under the brand name Plavix, was ...